@phiontx announce joint £1million @innovateuk award with @QUBelfast. To fund project developing a multi-antigenic therapeutic vaccine for prostate cancer, using pHion’s innovative technology.
https://t.co/sMUED7N49S
Delighted to be able to take some of our US partners to visit one of QUB’s spin-outs @pHionTx during their trip to Belfast for #Agreement25. Thanks to CEO and QUB Professor of Nanomedicine @Prof_H_McCarthy for the fantastic tour! #loveQUB
March 4, International HPV Awareness Day. @pHionTx is using its unique RALA technology to develop a therapeutic HPV vaccine. Taking the vaccine to clinical trials later this year, pHion is driving innovation to help tackle the global cancer burden. #cancer#vaccine
Day 2/5: We are shining a spotlight on some of the successful female scientists we partner with nationwide.
👉 Professor Helen McCarthy, CEO and Co-Founder, pHion (@pHionTx.
#WomenInScience @WomenScienceDaDay 2/5: We are shining a spotlight on some of the successful female scientists we partner with nationwide.
👉 Professor Helen McCarthy, CEO and Co-Founder, pHion (@pHionTx.
#WomenInScience @WomenScienceDaDay 2/5: We are shining a spotlight on some of the successful female scientists we partner with nationwide.
👉 Professor Helen McCarthy, CEO and Co-Founder, pHion (@pHionTx.
#WomenInScience@WomenScienceDay
Did you know there are around 3,200 new #cervicalcancer cases in the UK every year. @phiontx is developing a therapeutic HPV vaccine for the treatment of this disease. Help make #cervicalcancer a thing of the past @jostrust #wecan
The most effective treatment of #cancer remains a critical societal goal. Today at #Bionow@Prof_H_McCarthy will discuss @pHionTx's new delivery model for oncology drug development. Benefiting global patient health with its stealth-like delivery.
https://t.co/C815WwzXeY
Register Now! In this final webinar of a four-part series on #RNA, cohosted by @CRISPRjournal@GENbio, we will delve into the delivery question surrounding #mRNA research and therapeutics.
Don't miss this on 10/21: https://t.co/rTTaTQseRf
@Prof_H_McCarthy@TriLinkBioTech
.@pHionTx 's Head of Vaccine Development, Dr Cian McCrudden welcomed the opportunity to discuss with Christian Smeden @mabtech's about the use of IRS instrument for assessment of vaccine-induced T cell activation. At the World Vaccine Congress Europe #WVCEU#vaccine@crudofski
.CEO @Prof_H_McCarthy will be discussing stealth delivery of mRNA vaccines this afternoon at the Advances in Advanced Therapy Manufacture https://t.co/lN09Pt3MGn
pHion Therapeutics are saddened to learn of the loss of Her Majesty Queen Elizabeth II, the UK's longest serving monarch. We would like to express our deepest condolences and sympathies to the Royal Family.